ALTEOGEN Inc - Asset Resilience Ratio

Latest as of March 2026: 55.57%

ALTEOGEN Inc (196170) has an Asset Resilience Ratio of 55.57% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ALTEOGEN Inc (196170) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩405.35 Billion

≈ $274.70 Million USD Cash + Short-term Investments

Total Assets

₩729.47 Billion

≈ $494.35 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how ALTEOGEN Inc's Asset Resilience Ratio has changed over time. See 196170 net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down ALTEOGEN Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 196170 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩405.35 Billion	55.57%
Total Liquid Assets	₩405.35 Billion	55.57%

Asset Resilience Insights

Very High Liquidity: ALTEOGEN Inc maintains exceptional liquid asset reserves at 55.57% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

ALTEOGEN Inc Industry Peers by Asset Resilience Ratio

Compare ALTEOGEN Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	10.93%
CSL Ltd AU:CSL	Biotechnology	0.41%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
HLB Co. Ltd KQ:028300	Biotechnology	0.72%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	Biotechnology	87.20%
Tourmaline Bio Inc. NASDAQ:TRML	Biotechnology	77.17%
PharmaResources (Shanghai) Co. Ltd. A SHE:301230	Biotechnology	16.35%

Annual Asset Resilience Ratio for ALTEOGEN Inc (2014–2025)

The table below shows the annual Asset Resilience Ratio data for ALTEOGEN Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	52.04%	₩363.64 Billion ≈ $246.43 Million	₩698.74 Billion ≈ $473.53 Million	+6.75pp
2024-12-31	45.29%	₩185.25 Billion ≈ $125.54 Million	₩409.01 Billion ≈ $277.18 Million	+2.10pp
2023-12-31	43.19%	₩110.61 Billion ≈ $74.96 Million	₩256.10 Billion ≈ $173.56 Million	-8.76pp
2022-12-31	51.95%	₩127.54 Billion ≈ $86.43 Million	₩245.49 Billion ≈ $166.37 Million	-25.64pp
2021-12-31	77.59%	₩202.00 Billion ≈ $136.90 Million	₩260.34 Billion ≈ $176.43 Million	-6.36pp
2020-12-31	83.95%	₩133.66 Billion ≈ $90.58 Million	₩159.21 Billion ≈ $107.89 Million	+11.87pp
2019-12-31	72.08%	₩61.98 Billion ≈ $42.00 Million	₩85.98 Billion ≈ $58.27 Million	-0.09pp
2018-12-31	72.17%	₩51.52 Billion ≈ $34.91 Million	₩71.38 Billion ≈ $48.37 Million	-3.23pp
2017-12-31	75.40%	₩32.43 Billion ≈ $21.98 Million	₩43.01 Billion ≈ $29.15 Million	-2.43pp
2016-12-31	77.82%	₩37.32 Billion ≈ $25.29 Million	₩47.95 Billion ≈ $32.49 Million	+29.84pp
2015-12-31	47.99%	₩18.90 Billion ≈ $12.81 Million	₩39.39 Billion ≈ $26.69 Million	+9.39pp
2014-12-31	38.60%	₩14.65 Billion ≈ $9.93 Million	₩37.96 Billion ≈ $25.72 Million	--

pp = percentage points

About ALTEOGEN Inc

KQ:196170 Korea Biotechnology

Market Cap

$12.78 Billion

₩18.85 Trillion KRW

Market Cap Rank

#1874 Global

#46 in Korea

Share Price

₩352500.00

Change (1 day)

+1.00%

52-Week Range

₩289500.00 - ₩559000.00

All Time High

₩559000.00